Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT · NASDAQ Global Market
+$0.15 today
Vol 0.47M · Avg 0.43M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-39.81%
Period High
$23.16
Period Low
$5.90
Latest
$7.53
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Achieve Life Sciences, Inc.
NASDAQ:ACHV
$504.05M
Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
$349.69M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$348.12M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$267.28M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$243.37M
Zura Bio Limited
NASDAQ:ZURA
$238.96M
Voyager Therapeutics, Inc.
NASDAQ:VYGR
$223.86M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$215.85M
Immuneering Corporation
NASDAQ:IMRX
$157.74M
Humacyte, Inc.
NASDAQ:HUMA
$157.21M
What is the latest ARCT filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does ARCT have?
Intrinsic Alpha currently shows 20 recent filings for ARCT.
Explore More
Continue the stock analysis
Jump to another research area for this company.